TrialRespiratory research2024

CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD.

Mirco Govoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.